Transformation of the Wholesale Business and Reorganization into a Locally Focused Sales Organization
First written in FY2024-Q1. 9 of 10 entries say "Advanced", first in FY2024-Q2. Latest entry: 2026-08-05.
No other company in this theme has enough history to compare yet.
- 2026-08-05AdvancedEarnings
「In July, Toho Yakuhin implemented a large-scale organizational change and reorganized into 2 divisions, Sales and Logistics. Under the new organizational structure, we will move forward at speed toward achieving the new medium-term management plan.」
The reorganization of the wholesaling business progressed to the operational stage, with a 2-division structure comprising Sales and Logistics established to achieve the new medium-term management plan. - FY2026AdvancedAnnual report
「From this April, we have been transitioning to a more agile organizational structure, built on the foundations established during the medium-term management plan period.」
Regarding the transformation of the wholesale business, we transitioned in April 2026 to a more agile organizational structure built on the foundations established under the previous medium-term management plan. - FY2026-H1AdvancedAnnual report
「As part of the business transformation, we focused on developing the diagnostic reagent market through pharmaceutical MS by integrating pharmaceutical and diagnostic reagent operations. We also advanced personnel assignments in anticipation of separating sales from logistics, as well as the introduction of new delivery terminals and a delivery management system, toward the introduction of the team structure in April 2026.」
In addition to developing the diagnostic reagent market through pharmaceutical MS, we advanced personnel assignments, the introduction of new delivery terminals, and the introduction of a delivery management system toward the introduction of the team structure in April 2026. - FY2025-H1AdvancedAnnual report
「As part of the business transformation, we continued joint initiatives by pharmaceutical MSs and diagnostic-reagent MSs in preparation for the transition to a team structure centered on secondary medical care areas, scheduled to begin in April 2026. We also implemented organizational changes and personnel transfers in the sales and logistics divisions in July.」
Regarding the transition to a team structure centered on secondary medical service areas, we specified April 2026 as the target start date and implemented joint initiatives by pharmaceutical MS and diagnostic reagent MS, as well as organizational changes and personnel transfers in the sales and logistics divisions. - FY2024AdvancedAnnual report
「In July 2023, Toho Pharmaceutical Co., Ltd. made substantial organizational changes, centered on its sales division, and accelerated preparations to reorganize its sales structure around secondary medical service areas in order to promote initiatives rooted in local communities. We identified the integration of pharmaceutical and diagnostic reagent operations as a major theme of the transformation, advanced joint promotions by pharmaceutical MS and diagnostic reagent MS, and also worked to improve sales and delivery efficiency by consolidating and closing business locations and clarifying the roles of MS and EMS.」
For the transformation of the wholesale business, we identified a sales structure based on secondary medical service areas, joint promotions by pharmaceutical MS and diagnostic reagent MS, the consolidation and closure of business locations, and clarification of the roles of MS and EMS as initiatives for the full fiscal year. - FY2024-Q3AdvancedAnnual report
「As part of the business transformation, we advanced joint promotions by pharmaceutical MS and diagnostic reagent MS in order to promote the integration of pharmaceutical and diagnostic reagent operations, a major theme of the transformation of the wholesale business. With regard to the consolidation and closure of business locations, we are developing an optimal structure suited to local circumstances. During the fiscal period, in October 2023, the Tsuruga Sales Office of Hokuriku Toho Co., Ltd. was integrated into the Fukui Sales Office.」
We advanced joint promotions by pharmaceutical MS and diagnostic reagent MS, and in October 2023 integrated the Tsuruga Sales Office into the Fukui Sales Office. - FY2024-Q2AdvancedAnnual report
「As part of the business transformation, we made substantial organizational changes, centered on the sales division of Toho Pharmaceutical Co., Ltd., a consolidated subsidiary, in July to advance the transformation of the wholesale business, one of the specific initiatives identified in our plan. We reorganized the sales organization around secondary medical service areas to promote initiatives rooted in local communities. We are also advancing the integration of pharmaceutical and diagnostic reagent operations, the consolidation and closure of business locations, and the efficiency of sales and delivery operations by clarifying the roles of MS and EMS.」
In July 2023, Toho Pharmaceutical reorganized its sales division into an organization based on secondary medical service areas. It is also advancing the integration of pharmaceutical and diagnostic reagent operations, the consolidation and closure of business locations, and the efficiency of sales and delivery operations by clarifying the roles of MS and EMS. - FY2024-Q1First statedAnnual report
「As part of the business transformation, we made substantial organizational changes, centered on the sales division of Toho Pharmaceutical Co., Ltd., a consolidated subsidiary that forms the core of our wholesale business, in order to advance the transformation of the wholesale business, one of the specific initiatives identified in our plan. We reorganized the business into organizations and teams centered on functional zones, also known as secondary medical service areas, to promote initiatives rooted in local communities. We are also actively pursuing the integration of pharmaceutical and diagnostic reagent operations, as well as the consolidation and closure of business locations.」
Based on the transformation of the wholesale business set out in the medium-term management plan, Toho Pharmaceutical reorganized its sales division into an organization and team structure centered on functional zones, while advancing the integration of pharmaceutical and diagnostic reagent operations and the consolidation and closure of business locations.